CoChat

An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway

Open access

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Background: Sepsis-associated encephalopathy (SAE) is characterized by diffuse brain dysfunction, long-term cognitive impairment, and increased morbidity and mortality. The current treatment for SAE is mainly symptomatic; the lack of specific treatment options and a poor understanding of the underlying mechanism of disease are responsible for poor patient outcomes. Fgr is a member of the Src family of tyrosine kinases and is involved in the innate immune response, hematologic cancer, diet-induced obesity, and hemorrhage-induced thalamic pain. This study investigated the protection provided by an Fgr kinase inhibitor in SAE and the underlying mechanism(s) of action. Methods: A cecal ligation and puncture (CLP)-induced mouse sepsis model was established. Mice were treated with or without an Fgr inhibitor and a PGC-1α inhibitor/activator. An open field test, a novel object recognition test, and an elevated plus maze were used to assess neurobehavioral changes in the mice. Western blotting and immunofluorescence were used to measure protein expression, and mRNA levels were measured using quantitative PCR (qPCR). An enzyme-linked immunosorbent assay was performed to quantify inflammatory cytokines. Mitochondrial membrane potential and morphology were measured by JC-1, electron microscopy, and the MitoTracker Deep Red probe. Oxidative stress and mitochondrial dysfunction were analyzed. In addition, the regulatory effect of Fgr on sirtuin 1 (SIRT1) was assessed. Results: CLP-induced sepsis increased the expression of Fgr in the hippocampal neurons. Pharmacological inhibition of Fgr attenuated CLP-induced neuroinflammation, the survival rate, cognitive and emotional dysfunction, oxidative stress, and mitochondrial dysfunction. Moreover, Fgr interacted with SIRT1 and reduced its activity and expression. In addition, activation of SIRT1/PGC-1α promoted the protective effects of the Fgr inhibitor on CLP-induced brain dysfunction, while inactivation of SIRT1/PGC-1α counteracted the benefits of the Fgr inhibitor. Conclusions: To our knowledge, this is the first report of Fgr kinase inhibition markedly ameliorating SAE through activation of the SIRT1/PGC-1α pathway, and this may be a promising therapeutic target for SAE. Graphical Abstract:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-023-04345-7

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Hippocampal Fgr was increased in the CLP mouse model. A The mRNA levels of Src family kinase members in the hippocampus after CLP surgery (n = 3 for control mice; n = 4 for CLP mice; mean ± SEM, unpaired t-test, *p < 0.05). B Level of Fgr protein in the hippocampus of septic mice (n = 3, mean ± SEM, unpaired t-test, *p < 0.05). C, D Representative fluorescent images (C) and quantitative analysis (D) of Fgr in hippocampal neurons from septic mice (n = 3, mean ± SEM, unpaired t-test, ***p < 0.001). E Fgr was not co-localized with GFAP and Iba1 in the hippocampus of septic mice. Scale bar, 50 μm
Fig. 1 Hippocampal Fgr was increased in the CLP mouse model. A The mRNA levels of Src family kinase members in the hippocampus after CLP surgery (n = 3 for control mice; n = 4 for CLP mice; mean ± SEM, unpaired t-test, *p < 0.05). B Level of Fgr protein in the hippocampus of septic mice (n = 3, mean ± SEM, unpaired t-test, *p < 0.05). C, D Representative fluorescent images (C) and quantitative analysis (D) of Fgr in hippocampal neurons from septic mice (n = 3, mean ± SEM, unpaired t-test, ***p < 0.001). E Fgr was not co-localized with GFAP and Iba1 in the hippocampus of septic mice. Scale bar, 50 μmCC BY · PubMed Central
Fig. 2 Fgr inhibition ameliorated the survival rate and cognitive and emotional dysfunction of CLP-induced septic mice. A The survival rate of sham and septic mice treated with Fgr inhibitor TL02-59 (0 [NS], 1, 10, and 15 mg/kg) was recorded at 7 days. B, C Total distance and time spent in center areas during 5-min locomotor activity test in the OFT (n = 8–10, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ****p < 0.0001). D In the NORT, the recognition index of sham and TL02-59 treated septic mice (n = 8–10, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001, ****p < 0.0001). E, F In the EPM, time spent in open arms and entries of open arms (n = 8–10, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)
Fig. 2 Fgr inhibition ameliorated the survival rate and cognitive and emotional dysfunction of CLP-induced septic mice. A The survival rate of sham and septic mice treated with Fgr inhibitor TL02-59 (0 [NS], 1, 10, and 15 mg/kg) was recorded at 7 days. B, C Total distance and time spent in center areas during 5-min locomotor activity test in the OFT (n = 8–10, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ****p < 0.0001). D In the NORT, the recognition index of sham and TL02-59 treated septic mice (n = 8–10, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001, ****p < 0.0001). E, F In the EPM, time spent in open arms and entries of open arms (n = 8–10, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)CC BY · PubMed Central
Fig. 3 Fgr inhibition diminished microglial activation and neuroinflammation. A Representative image of Iba1 (red) and DAPI (blue) fluorescence in the hippocampus at different magnifications (scale bar, 50 μm or 20 μm). B, C Quantitative analysis of Iba1-positive cell number and soma area (n = 5 or 6 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). D, E Levels of IL-6 (D) and TNF-α (E) in the hippocampus (n = 6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ****p < 0.0001)
Fig. 3 Fgr inhibition diminished microglial activation and neuroinflammation. A Representative image of Iba1 (red) and DAPI (blue) fluorescence in the hippocampus at different magnifications (scale bar, 50 μm or 20 μm). B, C Quantitative analysis of Iba1-positive cell number and soma area (n = 5 or 6 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). D, E Levels of IL-6 (D) and TNF-α (E) in the hippocampus (n = 6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ****p < 0.0001)CC BY · PubMed Central
Fig. 4 Fgr inhibitor treatment suppressed ROS generation and mitochondrial injury in the hippocampus of septic mice. A Representative TEM image of mitochondria in the hippocampus (scale bar, 2 μm or 500 nm). B, C Statistical analysis of mitochondrial density and length (n = 5 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01). D Representative DHE staining fluorescence of ROS in the hippocampus (scale bar, 200 μm or 100 μm). E Relative level of ROS (normalized to the sham group) (n = 5 mice, 3–4 slices per mouse, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001). F ATP content in the hippocampus of the indicated groups (n = 5 or 7 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001). G–K Mitochondrial respiratory chain complex (I, II, III, IV, and V) enzyme activity in the hippocampus (n = 3 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001)
Fig. 4 Fgr inhibitor treatment suppressed ROS generation and mitochondrial injury in the hippocampus of septic mice. A Representative TEM image of mitochondria in the hippocampus (scale bar, 2 μm or 500 nm). B, C Statistical analysis of mitochondrial density and length (n = 5 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01). D Representative DHE staining fluorescence of ROS in the hippocampus (scale bar, 200 μm or 100 μm). E Relative level of ROS (normalized to the sham group) (n = 5 mice, 3–4 slices per mouse, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001). F ATP content in the hippocampus of the indicated groups (n = 5 or 7 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001). G–K Mitochondrial respiratory chain complex (I, II, III, IV, and V) enzyme activity in the hippocampus (n = 3 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001)CC BY · PubMed Central
Fig. 5 Effects of Fgr inhibitor on hippocampal activation of SIRT1, PGC-1α, and DRP1 pathways in CLP-induced septic mice. A Representative Western blot of SIRT1, PGC-1α, and DRP1. B–D Statistical analysis of SIRT1, PGC-1α, and DRP1 protein levels (n = 3 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001). E–G Representative fluorescent images and quantitative analysis of SIRT1, PGC-1α, and DRP1 in the neuron (labeled with NeuN) (n = 5 per group, 3–4 slices per mouse, scale bar = 20 μm, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001, ****p < 0.0001)
Fig. 5 Effects of Fgr inhibitor on hippocampal activation of SIRT1, PGC-1α, and DRP1 pathways in CLP-induced septic mice. A Representative Western blot of SIRT1, PGC-1α, and DRP1. B–D Statistical analysis of SIRT1, PGC-1α, and DRP1 protein levels (n = 3 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001). E–G Representative fluorescent images and quantitative analysis of SIRT1, PGC-1α, and DRP1 in the neuron (labeled with NeuN) (n = 5 per group, 3–4 slices per mouse, scale bar = 20 μm, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, **p < 0.01, ***p < 0.001, ****p < 0.0001)CC BY · PubMed Central
Fig. 6 Fgr interacted with SIRT1 and affected its activity. A, B Co-immunoprecipitation assay indicating that Fgr interacts with SIRT1 in the hippocampus of WT mice in vivo. C–F Representative Western blot and statistical analysis of Fgr and SIRT1 in HT22 mouse hippocampal neuronal cell line (n = 3, mean ± SEM, unpaired t-test, *p < 0.05). G SIRT1 activity in the hippocampus of septic mice (n = 3 or 4 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01). H SIRT1 activity in HT22 cells (n = 4, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, ***p < 0.001). I Schematic representation of mouse SIRT1 fragments. J Fgr enzymatic activity measured with a Universal Kinase Activity Kit and Shp2 as a substrate (n = 3 or 6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01)
Fig. 6 Fgr interacted with SIRT1 and affected its activity. A, B Co-immunoprecipitation assay indicating that Fgr interacts with SIRT1 in the hippocampus of WT mice in vivo. C–F Representative Western blot and statistical analysis of Fgr and SIRT1 in HT22 mouse hippocampal neuronal cell line (n = 3, mean ± SEM, unpaired t-test, *p < 0.05). G SIRT1 activity in the hippocampus of septic mice (n = 3 or 4 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01). H SIRT1 activity in HT22 cells (n = 4, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, ***p < 0.001). I Schematic representation of mouse SIRT1 fragments. J Fgr enzymatic activity measured with a Universal Kinase Activity Kit and Shp2 as a substrate (n = 3 or 6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01)CC BY · PubMed Central
Fig. 7 Effects of SIRT1 activation or inhibition on Fgr -mediated protection against oxidative damage and mitochondrial injury. A Mitochondrial morphology stained by MitoTracker Deep Red probe (n = 5, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ***p < 0.001, ****p < 0.0001). B, C Mitochondrial membrane potential assayed by JC-1 staining in HT22 cells and statistical analysis (n = 5, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ****p < 0.0001). D, E Representative image and statistical analysis of ROS production in HT22 cells stained with DCFH-DA (green) (n = 6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, ****p < 0.0001). F–H Relative ATP content (F), MDA content (G), and SOD activity (H) in HT22 cells (n = 3, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001)
Fig. 7 Effects of SIRT1 activation or inhibition on Fgr -mediated protection against oxidative damage and mitochondrial injury. A Mitochondrial morphology stained by MitoTracker Deep Red probe (n = 5, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ***p < 0.001, ****p < 0.0001). B, C Mitochondrial membrane potential assayed by JC-1 staining in HT22 cells and statistical analysis (n = 5, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ****p < 0.0001). D, E Representative image and statistical analysis of ROS production in HT22 cells stained with DCFH-DA (green) (n = 6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, ****p < 0.0001). F–H Relative ATP content (F), MDA content (G), and SOD activity (H) in HT22 cells (n = 3, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001)CC BY · PubMed Central
Fig. 8 Effects of PGC-1α activation on Fgr-mediated protection of oxidative damage, mitochondrial function, and cognitive and emotional behaviors. A Mitochondrial morphology stained by MitoTracker Deep Red probe (n = 5, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ***p < 0.001, ****p < 0.0001). B, C Mitochondrial membrane potential assayed by JC-1 staining in HT22 cells and statistical analysis (n = 3, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01). D, E Representative image and statistical analysis of ROS production in HT22 cells stained with DCFH-DA (green) (n = 5–6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, ****p < 0.0001). F–H Relative ATP content (F), MDA content (G), and SOD activity (H) in HT22 cells (n = 3, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001). I Recognition index in different groups (n = 7–9 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ****p < 0.0001). J Time spent in open arms in the EPM (n = 8–10 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ****p < 0.0001)
Fig. 8 Effects of PGC-1α activation on Fgr-mediated protection of oxidative damage, mitochondrial function, and cognitive and emotional behaviors. A Mitochondrial morphology stained by MitoTracker Deep Red probe (n = 5, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ***p < 0.001, ****p < 0.0001). B, C Mitochondrial membrane potential assayed by JC-1 staining in HT22 cells and statistical analysis (n = 3, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01). D, E Representative image and statistical analysis of ROS production in HT22 cells stained with DCFH-DA (green) (n = 5–6, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, ****p < 0.0001). F–H Relative ATP content (F), MDA content (G), and SOD activity (H) in HT22 cells (n = 3, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001). I Recognition index in different groups (n = 7–9 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, **p < 0.01, ****p < 0.0001). J Time spent in open arms in the EPM (n = 8–10 mice, mean ± SEM, one-way ANOVA with Bonferroni post hoc test, *p < 0.05, ****p < 0.0001)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Cited by

See all 80

Metadata

Authors
Liu, Y., Yang, H., Luo, N., Fu, Y., Qiu, F., Pan, Z., Li, X., Jian, W., Yang, X., Xue, Q., Luo, Y., Yu, B., & Liu, Z.
Affiliations
  • Shenzhen University (CN)
  • Guangdong Medical College (CN)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Liu, Yuqiang
  • Liu, Zhiheng
Venue
Journal of Translational Medicine
Published
2023-07-20
Volume
21
Issue
1
Pages
486-486
ISSN
1479-5876 (ISSN-L)
OpenAlex
W4384785020
Cited by
79
References
79
Citations by year
2026: 27 · 2025: 28 · 2024: 20 · 2023: 4
FWCI
15.77
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (82001138)
  • Science and Technology Planning Project of Shenzhen Municipality (JCYJ20190806164601647, JCYJ20220531092609020)
  • Sanming Project of Medicine in Shenzhen (SZSM201612026)
  • Guangdong Basic and Applied Basic Research Foundation (2022A1515111152)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
sepsis-associated encephalopathy, Src family kinases, SIRT1, PGC-1α, mitochondrial dysfunction, oxidative stress, neuroinflammation, hippocampal neurons, cognitive impairment, emotional dysfunction, cecal ligation and puncture, sepsis, neuroprotection
MeSH terms
Neuroinflammatory Diseases, Animals, Antineoplastic Agents, Disease Models, Animal, Mitochondria, Signal Transduction, Oxidative Stress, Sepsis, Mice, Sirtuin 1, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway. https://app.cochat.ai/papers/10.1186/s12967-023-04345-7
The paper
Liu, Y., Yang, H., Luo, N., Fu, Y., Qiu, F., Pan, Z., Li, X., Jian, W., Yang, X., Xue, Q., Luo, Y., Yu, B., & Liu, Z. (2023). An Fgr kinase inhibitor attenuates sepsis-associated encephalopathy by ameliorating mitochondrial dysfunction, oxidative stress, and neuroinflammation via the SIRT1/PGC-1α signaling pathway. Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-04345-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.